Authors: Blank; Gibson; Myers; Dierckman; Phipps; Smith

Source: Alimentary Pharmacology & Therapeutics, Volume 14, Number 9, September 2000 , pp. 1215-1223(9)

Publisher: Wiley-Blackwell

Abstract:

Background: 

The use of nitrogen-containing bisphosphonates (N-BPs) has been reported to be associated with gastrointestinal intolerance. The fasted, indomethacin-treated rat provides a model for assessing the gastrointestinal effects of these compounds. Aims: 

The aims of this study were to elucidate the effect of pH on N-BP-induced gastric damage, and to evaluate the structure-activity relationship between N-BP anti-resorptive and gastric effects. Methods: 

Fasted rats were dosed concomitantly with indomethacin (40 mg/kg, subcutaneously) and an N-BP (pamidronate, alendronate, or risedronate at 150 or 300 mg/kg, orally), with the N-BP dosing solutions adjusted to pH 2, 4 or 7. The aminopentane and aminohexane N-BPs (150, 225 or 300 mg/kg, orally) were only tested at pH 4 only. Results: 

Nitrogen-containing bisphosphonate-induced gastric damage was pH-dependent, with increased damage at increasing pH. Conclusions: 

Gastric damage potential did not correlate with bone anti-resorptive effects, and the more potent anti-resorptive N-BPs were not necessarily more damaging to the stomach.

Document Type: Research article

DOI: http://dx.doi.org/10.1046/j.1365-2036.2000.00816.x

Affiliations: 1: Department of Drug Safety Assessment, Procter & Gamble Pharmaceuticals, Health Care Research Center, 8700 Mason-Montgomery Road, Cincinnati, Ohio, USA

Publication date: 2000-09-01

Related content

• In this: publication
• By this: publisher
• In this Subject: Pathology ,  Pharmacology ,  Surgery ,  Therapeutics & Alternative Medicine
• By this author: Blank ;  Gibson ;  Myers ;  Dierckman ;  Phipps ;  Smith

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers